Enzyme compositions, steroid derivatives, enzyme inhibitors, and methods of making same for pharmaceutical applications

US11214591B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11214591-B2
Application numberUS-201916576406-A
CountryUS
Kind codeB2
Filing dateSep 19, 2019
Priority dateSep 19, 2018
Publication dateJan 4, 2022
Grant dateJan 4, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides for a synthetic strategy to incorporate a C12α-hydroxy group from the methylene (—CH2-) in a steroid backbone, combining synthetic chemistry and enzymology techniques to develop a selective inhibitor for cytochrome P450 8B1, and developing a selective P450 8B1 inhibitor, which can be used as a tool to study P450 8B1 and treat health issues.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound having a general formula (I) or a pharmaceutically acceptable salt thereof: 2. A compound having a general formula (II) or a pharmaceutically acceptable salt thereof: 3. The general formula of claim 1 , wherein the general formula is reductively animated to produce at least one derivative. 4. The at least one derivative of claim 3 , wherein the derivative is a 12-dimethylamino derivative. 5. The at least one derivative of claim 3 , wherein the derivative is a substrate of P450 8B1. 6. A pharmaceutical composition comprising the compound of claim 1 . 7. The general formula of claim 2 , wherein the general formula is reductively animated to produce at least one derivative. 8. The at least one derivative of claim 7 , wherein the derivative is a 12-dimethylamino derivative. 9. The at least one derivative of claim 7 , wherein the derivative is a substrate of P450 8B1. 10. A pharmaceutical composition comprising the compound of claim 2 .

Assignees

Inventors

Classifications

  • Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane · CPC title

  • not condensed · CPC title

  • Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00 · CPC title

  • containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton · CPC title

  • the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11214591B2 cover?
The present disclosure provides for a synthetic strategy to incorporate a C12α-hydroxy group from the methylene (—CH2-) in a steroid backbone, combining synthetic chemistry and enzymology techniques to develop a selective inhibitor for cytochrome P450 8B1, and developing a selective P450 8B1 inhibitor, which can be used as a tool to study P450 8B1 and treat health issues.
Who is the assignee on this patent?
Univ Texas
What technology area does this patent fall under?
Primary CPC classification C07J73/005. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).